Moshe Giladi - Chief Science Officer at NovoCure Ltd

Issuer-level insider activity

Role
Chief Science Officer
Issuer ticker
NVCR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Moshe Giladi since 02 Aug 2025

Reported holdings for Moshe Giladi in NovoCure Ltd

Form 4 holding Chief Science Officer

NovoCure Ltd

Security class
Stock Options (Right to buy)
Shares / value
78,174
Estimated value
$1,274,236
Report date
27 Feb 2024
Price
$16.30
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Science Officer

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
69,771
Estimated value
$1,137,267
Report date
27 Feb 2024
Price
$16.30
Ownership
Direct
Form 4 holding Chief Science Officer

NovoCure Ltd

Security class
Restricted Share Units
Shares / value
353
Estimated value
Report date
26 Jul 2023
Price
Ownership
Direct

Transaction history for Moshe Giladi in NovoCure Ltd

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .